EVO (Evotec SE) stock: $1.69, $601.2M market cap, $318.3M cash, $606.5M EV, $610.7M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
What they do
Our ambition is to lead the way by combining comprehensive disease understanding at the molecular level with cutting-edge technologies, transforming this knowledge into precise, life-changing medicines through collaborative partnerships. We aim to reshape the future of healthcare by providing flexible access for our partners in the pharmaceutical and biotechnology industry to our platform across the continuum of discovery, development and manufacturing.